Predictors of achieving remission in schizophrenia patients treated with paliperidone palmitate 3-month formulation

Predictors of achieving remission in schizophrenia patients treated with paliperidone palmitate 3-month formulation

Abigail I Nash,1 Ibrahim Turkoz,2 Adam J Savitz,2 Maju Mathews,2 Edward Kim1 1Janssen Scientific Affairs, LLC, Titusville, NJ 08560, USA; 2Janssen Research and Development, LLC, Titusville, NJ 08560, USA Purpose: Long-acting injectable (LAI) antipsychotic paliperidone palmitate 3-month formulation...

Full description

Bibliographic Details
Main Authors: Nash AI, Turkoz I, Savitz AJ, Mathews M, Kim E
Format: Article
Language:English
Published: Dove Medical Press 2019-03-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
long-acting injectable
symptomatic remission
double-blind treatment
Online Access:https://www.dovepress.com/predictors-of-achieving-remission-in-schizophrenia-patients-treated-wi-peer-reviewed-article-NDT

Internet

https://www.dovepress.com/predictors-of-achieving-remission-in-schizophrenia-patients-treated-wi-peer-reviewed-article-NDT

Similar Items